Cingal is a sterile intra-articular injectable designed for the symptomatic treatment of osteoarthritis. It combines cross-linked sodium hyaluronate with triamcinolone hexacetonide, providing both immediate anti-inflammatory relief and long-lasting joint lubrication.
The product is supplied as a single-use prefilled syringe intended for administration by qualified healthcare professionals.
Cingal combines two complementary therapeutic mechanisms.
The stabilized hyaluronic acid:
The corticosteroid component:
Together, these ingredients offer both immediate comfort and prolonged joint support.
Cingal may be used for symptomatic management of:
Treatment should always be prescribed by a qualified physician.
Each 4 ml prefilled syringe contains:
Cingal is administered only by intra-articular injection performed by a trained healthcare professional.
Joint aspiration may be performed before injection if clinically indicated.
Self-administration is not recommended.
Some patients may experience:
Seek medical advice if symptoms become severe or persistent.
Do not use in patients with:
Cingal is a combination intra-articular injection containing cross-linked hyaluronic acid and triamcinolone hexacetonide for osteoarthritis symptom relief.
It is primarily used for knee osteoarthritis but may also be considered for other large joints when clinically appropriate.
It combines viscosupplementation with a corticosteroid to provide both rapid pain relief and longer-lasting joint lubrication.
Many patients receive a single injection, although treatment decisions depend on the physician's assessment.
No. Administration should only be performed by qualified healthcare professionals.
Availability depends on local regulations and healthcare systems.
Ask a question or inquire about delivery to your country

